Prestige Consumer Healthcare, Inc. (PBH)
45.01
-0.25
(-0.55%)
USD |
NYSE |
Oct 05, 09:53
Prestige Consumer Healthcare Profit Margin (Quarterly) : 10.98% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.98% |
| March 31, 2026 | 19.15% |
| December 31, 2025 | 16.47% |
| September 30, 2025 | 15.40% |
| June 30, 2025 | 19.02% |
| March 31, 2025 | 16.91% |
| December 31, 2024 | 21.02% |
| September 30, 2024 | 19.16% |
| June 30, 2024 | 18.37% |
| March 31, 2024 | 17.86% |
| December 31, 2023 | 18.76% |
| September 30, 2023 | 18.71% |
| June 30, 2023 | 19.07% |
| March 31, 2023 | -84.15% |
| December 31, 2022 | 18.86% |
| September 30, 2022 | 17.64% |
| June 30, 2022 | 19.95% |
| March 31, 2022 | 19.51% |
| December 31, 2021 | 18.30% |
| September 30, 2021 | 16.41% |
| June 30, 2021 | 21.46% |
| March 31, 2021 | 14.94% |
| December 31, 2020 | 17.12% |
| September 30, 2020 | 18.78% |
| June 30, 2020 | 19.05% |
| Date | Value |
|---|---|
| March 31, 2020 | 14.75% |
| December 31, 2019 | 15.76% |
| September 30, 2019 | 13.97% |
| June 30, 2019 | 14.61% |
| March 31, 2019 | -57.78% |
| December 31, 2018 | 15.81% |
| September 30, 2018 | 12.88% |
| June 30, 2018 | 13.57% |
| March 31, 2018 | -15.50% |
| December 31, 2017 | |
| September 30, 2017 | 11.90% |
| June 30, 2017 | 13.16% |
| March 31, 2017 | 4.61% |
| December 31, 2016 | 14.60% |
| September 30, 2016 | 14.97% |
| June 30, 2016 | -2.64% |
| March 31, 2016 | 6.70% |
| December 31, 2015 | 13.98% |
| September 30, 2015 | 15.43% |
| June 30, 2015 | 13.62% |
| March 31, 2015 | 12.51% |
| December 31, 2014 | 10.78% |
| September 30, 2014 | 9.08% |
| June 30, 2014 | 11.48% |
| March 31, 2014 | 11.09% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -26.65% |
| Structure Therapeutics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.23% |
| Return on Assets | 4.65% |
| Return on Invested Capital | 5.52% |
| Gross Profit Margin (Quarterly) | 49.11% |
| Operating Margin (Quarterly) | 19.77% |
| Return on Net Operating Assets | 4.80% |